Literature DB >> 33593717

Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease.

Md Sayed Ali Sheikh1.   

Abstract

BACKGROUND: Coronary artery diseases are the most important cause of premature death, and these diseases are predominantly related to atherosclerosis. Soluble lectin-like oxidized low-density lipoprotein receptor-1 and microRNAs are closely associated with atherosclerotic coronary heart diseases. AIMS: To investigate the relationship between the severity and risk of coronary artery disease and plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 and miR-98. STUDY
DESIGN: Case-control study.
METHODS: Angiographically documented patients with 38 single-vessel, 75 double-vessel, and 62 multi-vessel coronary artery disease; 62 healthy control participants; and 24-hour hypoxic (1% oxygen) human umbilical vein endothelial cells were included in this study. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 concentrations were determined through enzyme-linked immunosorbent assays, and miR-98 expressions were measured by quantitative real-time polymerase chain reaction.
RESULTS: The expressions of plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 levels were progressively and significantly higher in patients with single-vessel, double-vessel, and multi-vessel coronary artery disease than in healthy controls (p<0.001). Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 concentrations in female patients with multi-vessel, double-vessel, and single-vessel coronary artery disease had evidently elevated compared with that in male patients (p<0.001). Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 levels were remarkably increased in females with coronary artery disease in different age groups compared with the males in the same age groups (p<0.001). Patients with single-vessel (areas under the curve=0.879), double-vessel (area under the curve=0.928), and multi-vessel (area under the curve=0.943) coronary artery disease have been clearly differentiated from healthy participants with respect to high sensitivity and specificity. The expression of miR-98 was noticeably downregulated in patients with single-, double- and multi-vessel occluded coronary artery disease and in hypoxic human umbilical vein endothelial cell compared with controls (p<0.001). Significantly elevated lectin-like oxidized low-density lipoprotein receptor-1 and caspase-3 activity and remarkably decreased cellular viability in hypoxic injured human umbilical vein endothelial cell. On the contrary, mimic of miR-98 markedly reduced caspase-3 and lectin-like oxidized low-density lipoprotein receptor-1 levels and highly increased cellular viability.
CONCLUSION: Elevated circulating plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 levels have a potential impact to identify the severity of coronary artery disease and have a strong correlation with aging as well as the female gender. Reduced plasma miR-98 level is possibly considered a risk factor for coronary artery disease, and agomiR-98 prevents atherosclerosis and cellular injury by targeting lectin-like oxidized low-density lipoprotein receptor-1.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33593717      PMCID: PMC8909218          DOI: 10.5152/balkanmedj.2021.20243

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  29 in total

1.  Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.

Authors:  Martine Paquette; Robert Dufour; Alexis Baass
Journal:  Can J Cardiol       Date:  2017-07-29       Impact factor: 5.223

2.  LOX index, a novel predictive biochemical marker for coronary heart disease and stroke.

Authors:  Nobutaka Inoue; Tomonori Okamura; Yoshihiro Kokubo; Yoshiko Fujita; Yuko Sato; Mamoru Nakanishi; Kazuki Yanagida; Akemi Kakino; Shin Iwamoto; Makoto Watanabe; Sayoko Ogura; Kazunori Otsui; Haruo Matsuda; Kagehiro Uchida; Ryo Yoshimoto; Tatsuya Sawamura
Journal:  Clin Chem       Date:  2010-01-21       Impact factor: 8.327

3.  Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.

Authors:  Sri H Kanuri; Joseph Ipe; Kameel Kassab; Hongyu Gao; Yunlong Liu; Todd C Skaar; Rolf P Kreutz
Journal:  Atherosclerosis       Date:  2018-10-03       Impact factor: 5.162

Review 4.  Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives.

Authors:  Kunming Tian; Sayoko Ogura; Peter J Little; Suo-Wen Xu; Tatsuya Sawamura
Journal:  Ann N Y Acad Sci       Date:  2018-11-01       Impact factor: 5.691

5.  Diagnostic Role of Plasma MicroRNA-21 in Stable and Unstable Angina Patients and Association with Aging.

Authors:  Md Sayed Ali Sheikh
Journal:  Cardiol Res Pract       Date:  2020-04-13       Impact factor: 1.866

6.  Detection of a High Ratio of Soluble to Membrane-Bound LOX-1 in Aspirated Coronary Thrombi From Patients With ST-Segment-Elevation Myocardial Infarction.

Authors:  An-Sheng Lee; Yu-Chen Wang; Shih-Sheng Chang; Ping-Hang Lo; Chia-Ming Chang; Jonathan Lu; Alan R Burns; Chu-Huang Chen; Akemi Kakino; Tatsuya Sawamura; Kuan-Cheng Chang
Journal:  J Am Heart Assoc       Date:  2020-01-13       Impact factor: 5.501

7.  Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.

Authors:  Zi-Wen Zhao; Yi-Wei Xu; Shu-Mei Li; Jin-Jian Guo; Jian-Min Sun; Ju-Chang Hong; Liang-Long Chen
Journal:  Dis Markers       Date:  2019-10-20       Impact factor: 3.434

8.  MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1.

Authors:  Yao Dai; Xiaoqin Wu; Dongsheng Dai; Jun Li; Jawahar L Mehta
Journal:  Redox Biol       Date:  2018-03-08       Impact factor: 11.799

9.  Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?

Authors:  Anja Hofmann; Coy Brunssen; Steffen Wolk; Christian Reeps; Henning Morawietz
Journal:  J Am Heart Assoc       Date:  2020-01-04       Impact factor: 5.501

10.  miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA.

Authors:  Shiwen Yuan; Chun Tang; Dongying Chen; Fangfei Li; Mingcheng Huang; Jinghua Ye; Zhixiang He; Weinian Li; Yi Chen; Xiaojun Lin; Xiaodong Wang; Xiaoyan Cai
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

View more
  2 in total

1.  Overexpression of miR-126 Protects Hypoxic-Reoxygenation-Exposed HUVEC Cellular Injury through Regulating LRP6 Expression.

Authors:  Md Sayed Ali Sheikh; A Almaeen; A Alduraywish; Basil Mohammed Alomair; Umme Salma; Li Fei; T L Yang
Journal:  Oxid Med Cell Longev       Date:  2022-01-17       Impact factor: 6.543

Review 2.  Effect of Dietary Fatty Acids on MicroRNA Expression Related to Metabolic Disorders and Inflammation in Human and Animal Trials.

Authors:  Karla MacDonald-Ramos; Alejandra Martínez-Ibarra; Adriana Monroy; Juan Miranda-Ríos; Marco Cerbón
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.